Similarly, Abu Aboud and colleagues demonstrated enhanced apoptosis in renal-cell carcinoma upon PPARα inhibition in vitro [193] and in vivo through a decrease in enhanced fatty-acid oxidation and oxidative phosphorylation, and further cancer-cell-specific glycolysis inhibition [194]. The gene discussed is PPARA; the disease is renal cell carcinoma.